The global AI in medical imaging market is set for an exceptional expansion trajectory, projected to grow at a CAGR of approximately 29%, with the market size expected to rise from USD 1.6 billion in 2024 to nearly USD 13 billion by 2032, according to DelveInsight’s latest market assessment.
This substantial surge is driven by a combination of rising chronic disease prevalence, accelerated technological innovation, government-led digital health initiatives, and expanding adoption of AI-powered diagnostic solutions across major healthcare systems worldwide.
AI-driven imaging technologies – leveraging deep learning, machine learning, and advanced computer vision – are revolutionizing diagnostic capabilities by improving accuracy, speed, and predictive performance, significantly boosting their integration into clinical workflows.
Download free sample report – AI in Medical Imaging Market
What Is AI in Medical Imaging?
AI in medical imaging applies machine learning and deep learning algorithms to interpret radiology images—including X-ray, CT, MRI, ultrasound, and PET scans – more efficiently and accurately than conventional methods. AI enhances diagnostic confidence, accelerates clinical workflows, reduces radiologist workloads, and minimizes diagnostic errors. It is increasingly essential in early disease detection, treatment planning, and real-time clinical decision support.
Recent Developments in AI in Medical Imaging Market
- August 2025: RIVANNA® received an $800,000 grant from the Virginia Catalyst Program to advance the AI-enabled Accuro® 3S diagnostic ultrasound system.
- August 2025: SmartAlpha’s Nerveblox, an AI software for ultrasound-guided anesthesia, obtained FDA 510(k) clearance, marking its entry into the U.S. market.
- April 2025: AI-assisted cardiac imaging software gained FDA approval, enabling non-experts to produce diagnostic-quality echocardiograms with minimal training.
- February 2025: RapidAI Lumina 3D obtained FDA 510(k) clearance, enabling near-instant 3D reconstructions from CTA scans, a breakthrough for neuroradiology applications.
Explore the Latest Breakthroughs in AI Imaging – Download the Sample Report Now @ Latest Advancements in AI in Medical Imaging Market
Regional AI in Medical Imaging Market Highlights
North America: Leading the Global AI in Medical Imaging Market
North America is expected to maintain its dominant position, accounting for over 42% of the global AI in medical imaging market share in 2024. The region benefits from:
- Robust healthcare infrastructure
- Strong presence of key AI and imaging technology developers
- Favorable regulatory support from the U.S. FDA
- Increased adoption of cloud-based diagnostic AI solutions
- Rising burden of chronic and lifestyle-related diseases
Strategic collaborations among research institutes, technology innovators, and healthcare providers continue to accelerate the deployment of cutting-edge AI applications.
Europe AI in Medical Imaging Market: Steady Growth Supported by Digitization
Europe is experiencing strong market momentum supported by widespread investment in precision medicine, national digital health initiatives, and advanced hospital networks. Germany, the U.K., France, and Switzerland are at the forefront of adopting AI-driven imaging systems to improve diagnostic accuracy and optimize hospital workflows.
Asia-Pacific AI in Medical Imaging Market: Fastest Emerging Region
Asia-Pacific is rapidly evolving into a key AI-in-imaging innovation hub with significant investments from China, Japan, South Korea, and India. Escalating rates of cancer, cardiovascular disorders, diabetes, and neurological conditions are boosting demand for AI-based analysis in CT, MRI, X-ray, and ultrasound imaging. Government-driven digital healthcare programs and expanding private healthcare infrastructure further enhance the region’s growth potential.
Stay Ahead in the USD 13 Billion AI Imaging Market – Download the Sample Report Instantly! @ AI in Medical Imaging Market Analysis
Key AI in Medical Imaging Market Drivers
Growing Burden of Chronic Diseases
The global rise in cancer, cardiovascular diseases, and neurological disorders is creating an urgent demand for high-precision diagnostic tools. AI-enhanced imaging systems enable rapid interpretation, detect subtle abnormalities, and help clinicians personalize care pathways. As disease complexity increases, AI tools provide essential support in interpreting the growing volume of imaging data, thus improving overall patient outcomes.
Rising Innovation and Product Development
Market-leading companies are heavily investing in R&D programs, next-generation imaging algorithms, and integrated AI-driven platforms. Strategic collaborations, mergers, and acquisitions are accelerating market penetration and enabling faster launch cycles of advanced diagnostic tools. Enhanced workflow automation, real-time image analysis, and cloud-based AI systems have further increased the clinical value of AI in imaging.
Government Support and Funding Initiatives
Government-funded digital health programs worldwide are significantly contributing to the adoption of AI in medical imaging. Public-sector funding, incentives for technological innovation, and supportive regulatory frameworks—such as expedited FDA approvals—are accelerating AI integration across hospitals and diagnostic centers. Policies promoting early screening, precision medicine, and cost-efficient care are further reinforcing market growth.
Explore Key Trends, Market Forecasts & Leading Players — Access the Free AI in Medical Imaging Sample Report! @ AI in Medical Imaging Companies
AI in Medical Imaging Market Landscape & Leading Players
Key companies operating in the global AI in medical imaging market include:
GE HealthCare, iRhythm Technologies, Royal Health Inc., Koninklijke Philips N.V., Abbott, Siemens Healthcare, Canon Medical Systems, Fujifilm Holdings, Hologic, AGFA Healthcare, IBM Watson Health, Zebra Medical Vision, Aidoc, TEMPUS, Enlitic, HeartFlow, Lunit, RadNet, Qure.ai, VUNO, among others.
AI in Medical Imaging Market Report Highlights
- AI in Medical Imaging Market Coverage: Global
- Study Period: 2022–2032
- CAGR (2025–2032): ~29%
- AI in Medical Imaging Market Size by 2032: ~USD 13 Billion
- Key AI in Medical Imaging Companies: GE HealthCare, Philips, Siemens, Fujifilm, Canon Medical Systems, Aidoc, Qure.ai, Lunit, IBM Watson Health, and others
- Segments Covered: Technology, Modality, Offering, Application, End-Users, Geography
Discover How AI Is Transforming Radiology – Get the Free Sample Report Now! @ AI in Medical Imaging Market Forecast
About DelveInsight
DelveInsight is a leading healthcare business consulting and market research firm focused on delivering deep, actionable intelligence across the pharmaceutical, biotechnology, and MedTech industries. With specialized expertise in market analysis, competitive intelligence, and pipeline evaluation, DelveInsight supports global organizations in making informed strategic decisions.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/competitive-intelligence-services